Skip to main content
Quest Diagnostics

Genetic Findings in a Cohort of 250 Patients with a Clinical Suspicion of Ectodermal Dysplasia

2023 National Society of Genetic Counselors (NSGC) Conference

NSGC 2023

Chicago, IL, October 17-21, 2023

Poster presentation: Genetic Findings in a Cohort of 250 Patients with a Clinical Suspicion of Ectodermal Dysplasia

Authors: Gall K, Sluyters A, Kaare M, Kyöstilä K, Dodge, W Hathaway J, Liaquat K, Partack E, Saarinen I, Kangas-Kontio T, Koskinen L, Seppala E, Alakurtti K, Martensson E, Muona M, Pietila T, Rantanen M, Gentile M, Salmenperä P, Myllykangas S, Koskenvuo J

Specialty: Genetics

Disclaimer: One or more of the authors of this abstract were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Related content

Conference Presentation
Perceived Barriers to Multistate Genetic Counseling Licensure in the United States: A Qualitative Study of Laboratory Genetic Counselors
The Utility of Exome Sequencing for Neurodevelopmental Disorders at a Large Reference Laboratory
Test FAQ
Chromosome Analysis, POC Tissue
Audio Podcast
Growing as a Laboratory Partner

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.